SILVER LAKE RESEARCH CORPORATION SBIR Phase II Award,

A SBIR Phase II contract was awarded to Silver Lake Research for $750,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

Overview Structured Data Issues Contributors Activity

sbir.gov/node/2580287

Is a

SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient

Silver Lake Research

Government Agency

Government Branch

National Institutes of Health

Award Type

SBIR0

Contract Number (US Government)

75N93023C000390

Award Phase

Phase II0

Award Amount (USD)

750,0000

Abstract

Silver Lake proposes to fully characterize mAb against 6 targets produced in their three concurrent Phase 1 projects that are relevant in models of disease and inflammation, determine their usability in multiple assay types, develop user protocols for each assay type and mAb, produce quality-controlled reagents, produce multiple conjugates for each mAb, and make all reagents available for the research community.